Lupus study watches immune system in kids on experimental treatment

This study is observing children with childhood-onset lupus who are receiving an experimental therapy called a bispecific T-cell engager. Researchers will take blood samples over time to track how the immune system changes. The goal is to find patterns that could help monitor the disease and guide future treatments. Only 6 children are being enrolled, so this is a very early, small study focused on learning, not on testing a new treatment.